{
    "clinical_study": {
        "@rank": "131152", 
        "arm_group": [
            {
                "arm_group_label": "Sustained virological response", 
                "description": "Patients who achieve sustained virological response (SVR) are defined as undetectable HCV RNA in serum obtained 12 weeks or beyond the end of antiviral therapy."
            }, 
            {
                "arm_group_label": "Non-responders", 
                "description": "Non-responders are defined as patients who have not achieved virological milestones during therapy or who have relapsed with detectable HCV RNA in serum after cessation of treatment."
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum and tissue collected through the UNC Liver Center serum and tissue bank."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine differences in levels of serum chemokines from\n      patients undergoing treatment with Boceprevir.  The aim is to determine if non-responders\n      have significantly different levels of chemokines than responders."
        }, 
        "brief_title": "Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatitis C", 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis C"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients undergoing standard of care at the UNC Liver Center are consented for collection of\n      an additional serum sample under the UNC Liver Center serum and tissue bank study.  These\n      samples will be used to analyze differences in serum chemokines across responders and\n      non-responders."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All adult patients (age 18 or older) treated with an antiviral Hepatitis C treatment\n             regimen that includes Boceprevir.\n\n        Exclusion Criteria:\n\n          -  Inability to provide informed consent for a serum sample enrolled in the University\n             of North Carolina Liver Center serum bank.\n\n          -  No pre and post serum sample available within 6 months of the treatment period."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Male and female adult patients: Aged 18 and older with chronic HCV treated with triple\n        therapy (including Boceprevir)."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01949077", 
            "org_study_id": "11-2124"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Hepatitis", 
            "Hepatitis C", 
            "Observational study", 
            "Biomarkers of treatment response"
        ], 
        "lastchanged_date": "September 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "University of North Carolina Liver Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.", 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Michael W Fried, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Compare levels of serum chemokines across Boceprevir responders (SVR) and non-responders for both Baseline (<=6-months pre-treatment) and Post-treatment (<=6-months post-treatment).", 
            "measure": "Level (ng/mL) of serum chemokines.", 
            "safety_issue": "No", 
            "time_frame": "Baseline: <=6 months prior to start of treatment and Post-treatment: <=6-months after the last dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01949077"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of North Carolina, Chapel Hill", 
            "investigator_full_name": "Michael Fried, MD", 
            "investigator_title": "Professor of Medicine, Director, UNC Liver Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of North Carolina, Chapel Hill", 
        "sponsors": {
            "collaborator": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of North Carolina, Chapel Hill", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}